Replimune Group Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year Ending	TTM	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	2018 - 2016
Net Income	-215.79	-215.79	-174.28	-118.04	-80.87	-52.63	Upgrade
Depreciation & Amortization	2.66	2.66	2.45	2.15	1.71	0.53	Upgrade
Share-Based Compensation	34.13	34.13	28.13	24.25	11.79	7.74	Upgrade
Other Operating Activities	-6.45	-6.45	15.66	9.46	5.98	-16.2	Upgrade
Operating Cash Flow	-185.47	-185.47	-128.05	-82.18	-61.39	-60.55	Upgrade
Capital Expenditures	-5.66	-5.66	-2.27	-2.34	-2.39	-6.54	Upgrade
Change in Investments	102.86	102.86	-140.23	0.53	-186.38	1.31	Upgrade
Investing Cash Flow	97.2	97.2	-142.5	-1.81	-188.78	-5.23	Upgrade
Share Issuance / Repurchase	1.76	1.76	283.51	6.86	383.5	90.58	Upgrade
Debt Issued / Paid	14.52	14.52	27.79	-0.26	-11.04	9.59	Upgrade
Financing Cash Flow	16.28	16.28	311.3	6.6	372.46	100.17	Upgrade
Exchange Rate Effect	-0.09	-0.09	-0.11	0.82	0.72	-0.14	Upgrade
Net Cash Flow	-72.07	-72.07	40.64	-76.57	123.02	34.25	Upgrade
Free Cash Flow	-191.13	-191.13	-130.32	-84.52	-63.78	-67.09	Upgrade
Free Cash Flow Per Share	-2.87	-2.87	-2.24	-1.62	-1.38	-1.96	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).